L'ETANG-Du Nord, Canada

Elyse Bourque

This inventor holds 0 USPTO granted patents, plus 4 CIPO patents.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Elyse Bourque. Retrieved from https://idiyas.com/inventor/elyse-bourque-7i95rjs3

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 1.0

ph-index = 1


Loading Chart...

Title: Elyse Bourque: Innovator in Pharmaceutical Research

Introduction

Elyse Bourque is a notable inventor based in L'Étang-Du Nord, Canada. She has made significant contributions to the field of pharmaceutical research, particularly in the development of treatments for respiratory viruses.

Latest Patents

Elyse Bourque holds a patent for "Bicyclic Fused Pyrazole Derivatives For The Treatment Of RSV." This patent discloses compounds of Formula lb, or pharmaceutically acceptable salts thereof, and compositions for treating or inhibiting RSV and related members of the pneumovirus and paramyxovirus families. These include human metapneumovirus, mumps virus, human parainfluenza viruses, and Nipah and Hendra virus, along with methods of treatment or prevention thereof. She currently has 0 patents.

Career Highlights

Elyse Bourque is associated with Vaxart, Inc., a company focused on innovative vaccine development. Her work is pivotal in advancing therapeutic options for viral infections.

Collaborations

Elyse collaborates with esteemed colleagues such as Richard K. Plemper and Eddy Lee, contributing to a dynamic research environment that fosters innovation.

Conclusion

Elyse Bourque's work in pharmaceutical research exemplifies her commitment to developing effective treatments for viral infections. Her contributions are vital in the ongoing battle against respiratory viruses.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…